Lantern Pharma annual capital expenditures (capex)
2021
2022
2023
2024
2025
Lantern Pharma Capital Expenditures (CapEx) Growth & History (LTRN)
Lantern Pharma's capital expenditures (capex) was $1,715 for fiscal 2025.
View full Lantern Pharma company overviewLantern Pharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1,715 | −$10,880 | −86.38% |
| 2024 | 2024-12-31 | $12,595 | −$6,139 | −32.77% |
| 2023 | 2023-12-31 | $18,734 | −$9,110 | −32.72% |
| 2022 | 2022-12-31 | $27,844 | $12,345 | +79.65% |
| 2021 | 2021-12-31 | $15,499 | — | — |
Lantern Pharma quarterly capital expenditures (capex)
Q3.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $1 | −$3,082 | −99.97% |
| Q3 2025 | 2025-09-30 | $555 | −$2,473 | −81.67% |
| Q2 2025 | 2025-06-30 | $0 | −$4,267 | — |
| Q1 2025 | 2025-03-31 | $1,159 | −$1,058 | −47.72% |
| Q4 2024 | 2024-12-31 | $3,083 | −$1,998 | −39.32% |
| Q3 2024 | 2024-09-30 | $3,028 | −$1,749 | −36.61% |
| Q2 2024 | 2024-06-30 | $4,267 | $4,267 | — |
| Q1 2024 | 2024-03-31 | $2,217 | −$6,659 | −75.02% |
| Q4 2023 | 2023-12-31 | $5,081 | — | — |
| Q3 2023 | 2023-09-30 | $4,777 | −$1,934 | −28.82% |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $8,876 | — | — |
| Q3 2022 | 2022-09-30 | $6,711 | $3,227 | +92.62% |
| Q3 2021 | 2021-09-30 | $3,484 | — | — |
Lantern Pharma capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Lantern Pharma's capital expenditures (capex) decreased from $15,499 to $1,715, a change of −$13,784. The latest reported quarter, Q4 2025, shows $1.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lantern Pharma source filings ↗